{"altmetric_id": 94089650, "counts": {"readers": {"citeulike": "0", "mendeley": "166", "connotea": "0"}, "total": {"posts_count": 22}, "twitter": {"unique_users_count": 9, "posts_count": 12}, "blogs": {"unique_users_count": 1, "unique_users": [59535], "posts_count": 1}, "news": {"unique_users_count": 9, "unique_users": ["crwe_world", "ticker_tech", "morning_star", "finanzen_ch", "pr_newswire", "the_street", "wfmz_tv_69", "biospace", "jotup"], "posts_count": 9}}, "citation": {"altmetric_jid": "medrxiv", "authors": ["Cao, Min", "Zhang, Dandan", "Wang, Youhua", "Lu, Yunfei", "Zhu, Xiangdong", "Li, Ying", "Xue, Honghao", "Lin, Yunxiao", "Zhang, Min", "Sun, Yiguo", "Yang, Zongguo", "Shi, Jia", "Wang, Yi", "Zhou, Chang", "Dong, Yidan", "Peng, Longping", "Liu, Ping", "Dudek, Steven M.", "Xiao, Zhen", "Lu, Hongzhou"], "doi": "10.1101/2020.03.04.20030395", "first_seen_on": "2020-11-11T11:54:10+00:00", "issns": [], "last_mentioned_on": 1591314451, "links": ["https://www.medrxiv.org/content/10.1101/2020.03.04.20030395v1", "https://www.medrxiv.org/content/10.1101/2020.03.04.20030395v1?utm_source=dlvr.it&utm_medium=twitter", "https://www.medrxiv.org/content/10.1101/2020.03.04.20030395v1.full.pdf", "https://c212.net/c/link/?t=0&l=en&o=2780763-1&h=2531570449&u=https://www.medrxiv.org/content/10.1101/2020.03.04.20030395v1&a=Cau+et+al+(medRxiv+2020)"], "pdf_url": "https://www.medrxiv.org/content/medrxiv/early/2020/03/06/2020.03.04.20030395.full.pdf", "pmid": "32511465", "publisher": "Cold Spring Harbor Laboratory", "title": "Clinical Features of Patients Infected with the 2019 Novel Coronavirus (COVID-19) in Shanghai, China", "type": "article", "mendeley_url": "https://www.mendeley.com/catalogue/5ee10d9f-47d1-3f29-a999-1ba88706f22c/"}, "altmetric_score": {"score": 72.08, "score_history": {"1y": 64.25, "6m": 0, "3m": 0, "1m": 0, "1w": 0, "6d": 0, "5d": 0, "4d": 0, "3d": 0, "2d": 0, "1d": 0, "at": 72.08}, "context_for_score": {"all": {"total_number_of_other_articles": 17446661, "mean": 9.3969963973021, "rank": 352396, "this_scored_higher_than_pct": 97, "this_scored_higher_than": 17095999, "rank_type": "exact", "sample_size": 17446661, "percentile": 97}, "similar_age_3m": {"total_number_of_other_articles": 382960, "mean": 16.387969579068, "rank": 14297, "this_scored_higher_than_pct": 96, "this_scored_higher_than": 368670, "rank_type": "exact", "sample_size": 382960, "percentile": 96}, "this_journal": {"total_number_of_other_articles": 18991, "mean": 55.203991996209, "rank": 1721, "this_scored_higher_than_pct": 90, "this_scored_higher_than": 17270, "rank_type": "exact", "sample_size": 18991, "percentile": 90}, "similar_age_this_journal_3m": {"total_number_of_other_articles": 2139, "mean": 66.994233754091, "rank": 254, "this_scored_higher_than_pct": 88, "this_scored_higher_than": 1886, "rank_type": "exact", "sample_size": 2139, "percentile": 88}}}, "demographics": {"poster_types": {"member_of_the_public": 8, "researcher": 1}, "users": {"twitter": {"cohorts": {"Members of the public": 8, "Scientists": 1}}, "mendeley": {"by_status": {"Student  > Postgraduate": 10, "Professor > Associate Professor": 6, "Researcher": 23, "Student  > Master": 18, "Student  > Ph. D. Student": 14, "Student  > Bachelor": 28, "Student  > Doctoral Student": 8, "Lecturer": 5, "Other": 11, "Librarian": 2, "Unspecified": 2}, "by_discipline": {"Medicine and Dentistry": 50, "Social Sciences": 4, "Sports and Recreations": 2, "Psychology": 2, "Mathematics": 1, "Pharmacology, Toxicology and Pharmaceutical Science": 4, "Unspecified": 2, "Chemical Engineering": 1, "Design": 1, "Engineering": 9, "Chemistry": 2, "Neuroscience": 1, "Earth and Planetary Sciences": 1, "Economics, Econometrics and Finance": 1, "Immunology and Microbiology": 5, "Computer Science": 3, "Agricultural and Biological Sciences": 9, "Nursing and Health Professions": 7, "Business, Management and Accounting": 4, "Biochemistry, Genetics and Molecular Biology": 10, "Veterinary Science and Veterinary Medicine": 1}}}, "geo": {"twitter": {"US": 5, "BE": 1}}}, "posts": {"twitter": [{"license": "gnip", "citation_ids": [94089650], "author": {"tweeter_id": "921400462838042624"}, "tweet_id": "1236005955239899139"}, {"license": "gnip", "citation_ids": [94089650], "author": {"tweeter_id": "3824923812"}, "tweet_id": "1236006769547022336"}, {"license": "gnip", "citation_ids": [94089650], "author": {"tweeter_id": "4901919879"}, "tweet_id": "1236278636958932995"}, {"license": "gnip", "citation_ids": [94089650], "author": {"tweeter_id": "4901919879"}, "tweet_id": "1236278684425781249"}, {"license": "gnip", "citation_ids": [94089650], "author": {"tweeter_id": "1233452224040382465"}, "tweet_id": "1247775653031600129"}, {"license": "gnip", "citation_ids": [94089650], "author": {"tweeter_id": "3294485143"}, "tweet_id": "1248824084990799872"}, {"license": "gnip", "citation_ids": [94089650], "author": {"tweeter_id": "3294485143"}, "tweet_id": "1248827197470588930"}, {"license": "gnip", "citation_ids": [94089650], "author": {"tweeter_id": "1106525887263109120"}, "tweet_id": "1252032676644741120"}, {"license": "gnip", "citation_ids": [94089650], "author": {"tweeter_id": "222674098"}, "tweet_id": "1253717007381512192"}, {"license": "gnip", "citation_ids": [94089650], "author": {"tweeter_id": "3057670547"}, "tweet_id": "1257963067792666624"}, {"license": "gnip", "citation_ids": [94089650], "author": {"tweeter_id": "3057670547"}, "tweet_id": "1257963782401413120"}, {"license": "gnip", "citation_ids": [94089650], "author": {"tweeter_id": "1265336030833422337"}, "tweet_id": "1268690878366748672"}], "blogs": [{"title": "COVID and Kidney: The AKI edition", "url": "http://feedproxy.google.com/~r/Blog-Nephjc/~3/JZq8VGuB2g4/covidaki", "license": "public", "citation_ids": [964442, 77337480, 77911636, 76810504, 75354095, 74723102, 94089544, 94089135, 77337480, 77872261, 78664660, 76597096, 94118537, 94089650, 78486313, 79202166, 79457285, 94089135, 79486308, 69757868, 94083313, 94083030, 77348517, 78651983, 94079537, 81584992, 4289592, 1739445, 38826720, 80338408, 94086661, 76981184, 94089134, 94082113, 78378316, 7485368, 49486988, 8272964, 7485368, 525681, 102363707, 77525147, 50438509, 1604621, 1950265, 81585000, 12233587, 29002335, 79016549, 32297288, 21166318, 79811069, 3193883, 2305077, 78402139, 81369980, 21398924, 56591379, 2971550, 2731182, 2365648, 74464078], "posted_on": "2020-03-21T22:55:22+00:00", "summary": "PreambleAs with all the other pages on COVID-19 here on NephJC, these are not meant to be treatment recommendations based on sound evidence. The data we have so far is mostly anecdotal: stories, a few case series and the occasional published study (sometim", "author": {"name": "Blog - NephJC", "url": "http://www.nephjc.com/news/", "description": ""}}], "news": [{"title": "KidneyIntelX\u2122 to Predict Major Adverse Kidney Events in COVID-19 Patients", "url": "http://ct.moreover.com/?a=41920972172&p=1pl&v=1&x=GH6-vkbM502X6qknfSfldA", "license": "public", "citation_ids": [77337480, 77872261, 78378316, 94082113, 77911636, 94089650, 94079537, 79457285, 78378316, 94082113, 79457285], "posted_on": "2020-04-20T11:34:07+00:00", "summary": "NEW YORK, April 20, 2020 /PRNewswire/ -- Renalytix AI plc (LSE: RENX), the AIM-traded developer of clinical grade artificial intelligence in vitro diagnostics for kidney disease, announces that the KidneyIntelX\u2122 platform will be used by\u2026", "author": {"name": "Crwe World", "url": "http://crweworld.com/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/004/344/normal/Capture_crwe.PNG?1574923200"}}, {"title": "KidneyIntelX\u2122 to Predict Major Adverse Kidney Events in COVID-19 Patients", "url": "http://ct.moreover.com/?a=41920987391&p=1pl&v=1&x=LtMe6JgK_cSpzO97gOh36g", "license": "public", "citation_ids": [77337480, 77872261, 78378316, 94082113, 77911636, 94089650, 94079537, 79457285, 78378316, 94082113, 79457285], "posted_on": "2020-04-20T11:35:58+00:00", "summary": "NEW YORK, April 20, 2020 /PRNewswire/ -- Renalytix AI plc (LSE: RENX), the AIM-traded developer of clinical grade artificial intelligence in vitro diagnostics for kidney disease, announces that the KidneyIntelX\u2122 platform will be used by\u2026", "author": {"name": "Ticker Tech", "url": "http://www.tickertech.com", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/001/724/normal/Screen_Shot_2016-01-26_at_15.37.40.png?1453822700"}}, {"title": "KidneyIntelX\u2122 to Predict Major Adverse Kidney Events in COVID-19 Patients", "url": "http://ct.moreover.com/?a=41921002515&p=1pl&v=1&x=Qaf0_DaE5K6VOWXUpvaZsQ", "license": "public", "citation_ids": [77337480, 77872261, 78378316, 94082113, 77911636, 94089650, 94079537, 79457285, 78378316, 94082113, 79457285], "posted_on": "2020-04-20T11:30:00+00:00", "summary": "KidneyIntelX\u2122 to Predict Major Adverse Kidney Events in COVID-19 Patients PR Newswire NEW YORK, April 20, 2020 NEW YORK, April 20, 2020 /PRNewswire/ -- Renalytix AI plc (LSE: RENX), the AIM-traded developer of clinical grade artificial intelligence\u2026", "author": {"name": "Morning Star", "url": "https://www.morningstar.com/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/002/912/normal/Screen_Shot_2018-09-17_at_18.20.59.png?1537204915"}}, {"title": "KidneyIntelX\u2122 to Predict Major Adverse Kidney Events in COVID-19 Patients", "url": "http://ct.moreover.com/?a=41921036731&p=1pl&v=1&x=Iy0f8kgO6iRcPYvSJspFQQ", "license": "public", "citation_ids": [78378316, 94082113, 79457285, 77337480, 77872261, 78378316, 94082113, 77911636, 94089650, 94079537, 79457285], "posted_on": "2020-04-20T11:44:13+00:00", "summary": "/PRNewswire/ -- Renalytix AI plc (LSE: RENX), the AIM-traded developer of clinical grade artificial intelligence in vitro diagnostics for kidney disease, announces that the KidneyIntelX\u2122 platform will be used by investigators from the Icahn School\u2026", "author": {"name": "Finanzen.ch", "url": "https://www.finanzen.ch/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/004/573/normal/Capture26.PNG?1575886265"}}, {"title": "KidneyIntelX\u2122 to Predict Major Adverse Kidney Events in COVID-19 Patients", "url": "http://ct.moreover.com/?a=41921043110&p=1pl&v=1&x=2-ajb3q5PLuuONWzx7sYlw", "license": "public", "citation_ids": [77337480, 77872261, 78378316, 94082113, 77911636, 94089650, 94079537, 79457285, 78378316, 94082113, 79457285], "posted_on": "2020-04-20T11:30:00+00:00", "summary": "/PRNewswire/ -- (LSE: RENX), the AIM-traded developer of clinical grade artificial intelligence in vitro diagnostics for kidney disease, announces that the KidneyIntelX\u2122 platform will be used by investigators from the Icahn School of Medicine at\u2026", "author": {"name": "PR Newswire", "url": "http://www.prnewswire.com/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/001/545/normal/Screen_Shot_2016-01-06_at_16.29.18.png?1452097789"}}, {"title": "KidneyIntelX\u2122 To Predict Major Adverse Kidney Events In COVID-19 Patients", "url": "http://ct.moreover.com/?a=41921102077&p=1pl&v=1&x=uAUZgoSy4nleFq-TMG6T3A", "license": "public", "citation_ids": [77337480, 77872261, 78378316, 94082113, 77911636, 94089650, 94079537, 79457285, 78378316, 94082113, 79457285], "posted_on": "2020-04-20T11:30:00+00:00", "summary": "/PRNewswire/ -- Renalytix AI plc (LSE: RENX), the AIM-traded developer of clinical grade artificial intelligence in vitro diagnostics for kidney disease, announces that the KidneyIntelX\u2122 platform will be used by investigators...", "author": {"name": "The Street", "url": "http://www.thestreet.com", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/001/809/normal/Screen_Shot_2016-01-27_at_10.05.56.png?1453889412"}}, {"title": "KidneyIntelX(TM) to Predict Major Adverse Kidney Events in COVID-19 Patients", "url": "http://ct.moreover.com/?a=41921141577&p=1pl&v=1&x=z53XR45Sdj0UjULD5id9sg", "license": "public", "citation_ids": [77337480, 77872261, 78378316, 94082113, 77911636, 94089650, 94079537, 79457285, 78378316, 94082113, 79457285], "posted_on": "2020-04-20T11:30:00+00:00", "summary": "/PRNewswire/ -- Renalytix AI plc (LSE: RENX), the AIM-traded developer of clinical grade artificial intelligence in vitro diagnostics for kidney disease, announces that the KidneyIntelX\u2122 platform will be used by investigators from the Icahn School\u2026", "author": {"name": "WFMZ-TV 69", "url": "https://www.wfmz.com/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/003/256/normal/Capture_62.PNG?1567141986"}}, {"title": "KidneyIntelX\u2122 to Predict Major Adverse Kidney Events in COVID-19 Patients", "url": "http://ct.moreover.com/?a=41921197318&p=1pl&v=1&x=5-5SxlRJtH8gMk9h5ASe9A", "license": "public", "citation_ids": [77337480, 77872261, 78378316, 94082113, 77911636, 94089650, 94079537, 79457285, 78378316, 94082113, 79457285], "posted_on": "2020-04-20T12:06:55+00:00", "summary": "NEW YORK, April 20, 2020 /PRNewswire/ -- (LSE: RENX), the AIM-traded developer of clinical grade artificial intelligence in vitro diagnostics for kidney disease, announces that the KidneyIntelX\u2122 platform will be used by investigators from the\u2026", "author": {"name": "Biospace", "url": "http://www.biospace.com", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/001/375/normal/biospace.png?1437140433"}}, {"title": "KidneyIntelX\u2122 to Predict Major Adverse Kidney Events in COVID-19 Patients", "url": "http://ct.moreover.com/?a=41921430858&p=1pl&v=1&x=aEphluOgCZTCBVHRJbqDdA", "license": "public", "citation_ids": [77337480, 77872261, 78378316, 94082113, 77911636, 94089650, 94079537, 79457285, 78378316, 94082113, 79457285], "posted_on": "2020-04-20T12:40:02+00:00", "summary": "Acute and chronic kidney disease is strongly associated with severity of disease and fatal outcomes in COVID-19 patients.", "author": {"name": "Jotup", "url": "https://jotup.co/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/003/231/normal/jotup-logo.png?1567071493"}}]}, "score": 72.08, "images": {"small": "https://badges.altmetric.com/?size=64&score=73&types=mmmbtttt", "medium": "https://badges.altmetric.com/?size=100&score=73&types=mmmbtttt", "large": "https://badges.altmetric.com/?size=180&score=73&types=mmmbtttt"}}